Related references
Note: Only part of the references are listed.Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment
Daniel Ajona et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Health benefits of resveratrol: Evidence from clinical studies
Akhand Pratap Singh et al.
MEDICINAL RESEARCH REVIEWS (2019)
A rational search for discovering potential neutraligands of human complement fragment 5a (hC5a)
Richa Mishra et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
The effects of polyphenols and other bioactives on human health
Cesar G. Fraga et al.
FOOD & FUNCTION (2019)
Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF-B in animal models of acute pharyngitis
Zhong-Xin Zhou et al.
MOLECULAR MEDICINE REPORTS (2018)
Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells
Yuwan Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Resveratrol and Related Stilbenoids, Nutraceutical/Dietary Complements with Health-Promoting Actions: Industrial Production, Safety, and the Search for Mode of Action
Gemma Navarro et al.
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2018)
Orthosteric and allosteric action of the C5a receptor antagonists
Heng Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Orthosteric and allosteric action of the C5a receptor antagonists
Heng Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
The Model Structures of the Complement Component 5a Receptor (C5aR) Bound to the Native and Engineered hC5a
Amita Rani Sahoo et al.
SCIENTIFIC REPORTS (2018)
C5a anaphylatoxin and its role in critical illness-induced organ dysfunction
Alexander J. T. Wood et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727
Nathan Robertson et al.
NATURE (2018)
Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets
Uzma Saqib et al.
FRONTIERS IN PHARMACOLOGY (2018)
Antioxidant effects of resveratrol in the cardiovascular system
Ning Xia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance
Giang T. Nguyen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
The therapeutic potential of resveratrol: a review of clinical trials
Adi Y. Berman et al.
NPJ PRECISION ONCOLOGY (2017)
Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs
J. Chen et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects
S. Biesinger et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling
Soumendra Rana et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)
Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling
Soumendra Rana et al.
MOLECULAR BIOSYSTEMS (2016)
Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation
Xuben Hou et al.
SCIENTIFIC REPORTS (2016)
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Verena Katharina Raker et al.
FRONTIERS IN IMMUNOLOGY (2016)
Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms
Robert G. Britton et al.
RESVERATROL AND HEALTH (2015)
Lifespan and healthspan extension by resveratrol
Khushwant S. Bhullar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
The molecular targets of resveratrol
Sameer S. Kulkarni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol
Duanfang Cao et al.
GENES & DEVELOPMENT (2015)
Characterization of resveratrol-milk protein interaction
Elham Ghorbani Gorji et al.
JOURNAL OF FOOD ENGINEERING (2015)
Study on the interactions of trans-resveratrol and curcumin with bovine α-lactalbumin by spectroscopic analysis and molecular docking
Fakhrossadat Mohammadi et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2015)
Intrinsically disordered proteins in cellular signalling and regulation
Peter E. Wright et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R. Scott Turner et al.
NEUROLOGY (2015)
An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol
Ashim Malhotra et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
Hong Cai et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Intrinsically Disordered Proteins and Intrinsically Disordered Protein Regions
Christopher J. Oldfield et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Oxicams Bind in a Novel Mode to the Cyclooxygenase Active Site via a Two-water-mediated H-bonding Network
Shu Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
The Cation-π Interaction
Dennis A. Dougherty
ACCOUNTS OF CHEMICAL RESEARCH (2013)
Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
S. Bo et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Resveratrol for primary prevention of atherosclerosis: Clinical trial evidence for improved gene expression in vascular endothelium
Beamon Agarwal et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms
Daniel Ricklin et al.
JOURNAL OF IMMUNOLOGY (2013)
Binding Sites of Resveratrol, Genistein, and Curcumin with Milk α- and β-Caseins
P. Bourassa et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Finding a Target for Resveratrol
Ruth I. Tennen et al.
CELL (2012)
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung-Jun Park et al.
CELL (2012)
trans-Resveratrol in Nutraceuticals: Issues in Retail Quality and Effectiveness
Damiano Rossi et al.
MOLECULES (2012)
Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae
Celine Riviere et al.
NATURAL PRODUCT REPORTS (2012)
Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast Cancer
Weizhu Zhu et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Bioavailability of resveratrol
Thomas Walle
RESVERATROL AND HEALTH (2011)
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Barbara Calamini et al.
BIOCHEMICAL JOURNAL (2010)
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus
Nick S. Laursen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway
Eun-Seok Park et al.
VASCULAR PHARMACOLOGY (2010)
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions
Laurent Camont et al.
ANALYTICA CHIMICA ACTA (2009)
Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities
Priya D. A. Issuree et al.
FASEB JOURNAL (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
Douglas R. Davies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Cyclic AMP - Master regulator of innate immune cell function
Carlos H. Serezani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Interaction of beta-Lactoglobulin with resveratrol and its biological implications
Li Liang et al.
BIOMACROMOLECULES (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Probing the interaction of trans-resveratrol with bovine serum albumin: A fluorescence quenching study with Tachiya model
J. B. Xiao et al.
JOURNAL OF FLUORESCENCE (2008)
EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol
Zhenquan Jia et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Resveratrol directly targets COX-2 to inhibit carcinogenesis
Tatyana A. Zykova et al.
MOLECULAR CARCINOGENESIS (2008)
Effect of glycosylation on protein folding: A close look at thermodynamic stabilization
Dalit Shental-Bechor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Resveratrol binding to human serum albumin
C. N. N'soukpoe-Kossi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2006)
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity
Joydeb Kumar Kundu et al.
CARCINOGENESIS (2006)
Using circular dichroism spectra to estimate protein secondary structure
Norma J. Greenfield
NATURE PROTOCOLS (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mammalian G proteins and their cell type specific functions
N Wettschureck et al.
PHYSIOLOGICAL REVIEWS (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Resveratrol analogues as selective cyclooxygenase-2 inhibitors:: synthesis and structure-activity relationship
M Murias et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)